Variant report
Variant | nsv597882 |
---|---|
Chromosome Location | chr5:41902330-41903101 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr5:41903074-41905268 | GM12878 | blood: | n/a | n/a |
2 | STAT3 | chr5:41902992-41903062 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:40833991..40836420-chr5:41902681..41904929,3 | K562 | blood: | |
2 | chr19:35739945..35740464-chr5:41903086..41904056,2 | Hela-S3 | cervix: | |
3 | chr5:41867500..41871930-chr5:41901815..41908844,17 | K562 | blood: | |
4 | chr5:41865404..41878163-chr5:41900217..41908471,28 | K562 | blood: | |
5 | chr5:41901802..41904243-chr5:43119565..43121157,2 | K562 | blood: | |
6 | chr5:41903013..41905286-chr5:41924628..41927661,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
C5orf51 | TF binding region |
ENSG00000083720 | chromatin interactions |
ENSG00000105699 | chromatin interactions |
ENSG00000151876 | chromatin interactions |
ENSG00000172262 | chromatin interactions |
ENSG00000145592 | chromatin interactions |
ENSG00000248668 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576857720 | chr5:41902368-41902369 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs138883427 | chr5:41902370-41902371 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs562692075 | chr5:41902372-41902373 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs530139656 | chr5:41902420-41902421 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs548326977 | chr5:41902472-41902473 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs560106761 | chr5:41902519-41902520 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs527555388 | chr5:41902539-41902540 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs544043342 | chr5:41902545-41902546 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs542501572 | chr5:41902604-41902605 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs35194817 | chr5:41902639-41902640 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs78222126 | chr5:41902687-41902688 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs277411 | chr5:41902711-41902712 | Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs186580747 | chr5:41902725-41902726 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs367724937 | chr5:41902753-41902754 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs556935569 | chr5:41902835-41902836 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs529642923 | chr5:41902890-41902891 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs537882027 | chr5:41902891-41902892 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs549804468 | chr5:41902911-41902912 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs568121522 | chr5:41902934-41902935 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs535212417 | chr5:41902955-41902956 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs572043053 | chr5:41902986-41902987 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
22 | rs141350705 | chr5:41902992-41902993 | Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
23 | rs114902804 | chr5:41903015-41903016 | Weak transcription Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
24 | rs534489082 | chr5:41903019-41903020 | Weak transcription Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
25 | rs563410710 | chr5:41903032-41903033 | Weak transcription Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
26 | rs559025553 | chr5:41903060-41903061 | Weak transcription Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
27 | rs16872021 | chr5:41903101-41903102 | Weak transcription Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 7 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hepatocellular carcinoma | 18929564 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:41899600-41903200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr5:41900000-41903800 | Weak transcription | Gastric | stomach |
3 | chr5:41900400-41903600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
4 | chr5:41903000-41903200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr5:41903000-41903400 | Enhancers | HepG2 | liver |
6 | chr5:41903000-41903600 | Active TSS | Fetal Brain Male | brain |
7 | chr5:41903000-41904000 | Flanking Active TSS | Dnd41 | blood |
8 | chr5:41903000-41905200 | Active TSS | Brain Hippocampus Middle | brain |